Presentations

1. CHALLENGES IN THE IMPLEMENTATION OF PRECISION MEDICINE

Opening Address Ron Zimmern: “Health Systems and the Future of Personalized Medicine: A Population Health Perspective”

 

Part I: The Healthcare System 

Keynote Henry T. Greely: “Precision Medicine: The Ethical, Legal, and Practical Challenges Ahead.”

Presentations Jeff Skopek: “Precision Rationing: The Law and Ethics of Differentiation.” Ock-Joo Kim & Yoon-Jung Chang: “Precision Medicine Ethics: Prospects on Clinical Application and Ethical Issues”

 

Part II: Medical Treatment

Keynote I. Glenn Cohen: “Legal and Ethical Issues in Using Big Data for Predictive Analytics in Health Care.”

Presentations Terry Kaan: “Genetic Information and the Family: the Future of the Duty of Disclosure and the Limits of Confidentiality” Tracey Evans Chan: “Regulatory Challenges of Innovative Therapeutics and Diagnostics in Medical Practice” Colm McGrath: “Liability for Failure to Disclose and the Challenge of Precision Medicine” Darrell Rowbottom: “On Probabilities in Personalised Medicine.”

 

II. CHALLENGES IN THE DEVELOPMENT OF PRECISION MEDICINE

Part I: Foundational Research

Keynote Bartha Maria Knoppers: “Activating the Right of Citizens to Benefit from Scientific Advances”

Presentations Kazuto Kato: “Genomic Medicine in Japan: Recent Developments in National Policy, and New Ethical and Legal Challenges“ Yann Joly: “Controlled Data Access for Precision Medicine: An Acceptable Trade-off?” Alison Hall: “Harm, Discretion or Duty: The Changing Nature of the Return of Individualised Results in Genetics Research.” Janice Tsang: “Precision Medicine for Cancer Care – Prime Time versus Provocation Threat?”

 

Part II: Translational Medicine

Keynote Donald Chalmers: “Has the Biobank Bubble Burst: A Translational Challenge?”

Presentations Kathy Liddell & John Liddicoat: “The Changing IP Landscape for Precision Medicine” Chih-Hsing Ho: “From Bench to Bedside: Secondary Use of Health Data for Precision Medicine“ Stuart Hogarth: “Lost on Planet Biomarker? Standards, Pathways, Carrots and Sticks for Diagnostic Development in the Post-genomic Era.” Timo Minssen: “Lost in Translation? Opportunities & Risks of Increased Research & Clinical Trials Data Transparency”